Pentax Medical obtained a CE Mark for its DEC Duodenoscope.
VolitionRx is planning a European launch of its CRC screening product in 2018.
Immuron is making progress on its three clinical trials for IMM-124E, a nonalcoholic steatohepatitis and nonalcoholic fatty liver disease treatment.
More articles on gastroenterology:
GI leader to know: Dr. Francis Farraye of Boston Medical Center
Stock market week-in-review for 5 large GI companies — Sept. 11-15
Patient engagement, case conference less effective in IBD care than perceived
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.